202
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

De novo designed EBAI as a potential inhibitor of the viral protein BHRF1. Research in silico

ORCID Icon, &
Pages 3680-3685 | Received 05 Mar 2021, Accepted 09 Mar 2022, Published online: 22 Mar 2022

References

  • Abraham, M., Murtola, T., Schulz, R., Páll, S., Smith, J., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
  • Albanese, M., Tagawa, T., Bouvet, M., Maliqi, L., Lutter, D., Hoser, J., Hastreiter, M., Hayes, M., Sugden, B., Martin, L., Moosmann, A., & Hammerschmidt, W. (2016). Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America, 113(42), E6467–E6475. https://doi.org/10.1073/pnas.1605884113
  • Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
  • Cirac, A., Poirey, R., Dieckmeyer, M., Witter, K., Delecluse, H. J., Behrends, U., & Mautner, J. (2021). Immunoinformatic analysis reveals antigenic heterogeneity of Epstein-Barr virus is immune-driven. Frontiers in Immunology, 12, 796379. https://doi.org/10.3389/fimmu.2021.796379
  • Cohen, J. I., Fauci, A. S., Varmus, H., & Nabel, G. J. (2011). Epstein-Barr virus: An important vaccine target for cancer prevention. Science Translational Medicine, 3(107), 107fs7. https://doi.org/10.1126/scitranslmed.3002878
  • de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012). Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. The Lancet. Oncology, 13(6), 607–615. https://doi.org/10.1016/S1470-2045(12)70137-7
  • DeLano, W. (2002). Pymol: An open-source molecular graphics tool. CCP4 Newsletter on Protein Crystallography, 40(1), 82–92.
  • Fitzsimmons, L., & Kelly, G. L. (2017). EBV and apoptosis: The viral master regulator of cell fate? Viruses, 9(11), 339. https://doi.org/10.3390/v9110339
  • Galluzzi, L., Brenner, C., Morselli, E., Touat, Z., & Kroemer, G. (2008). Viral control of mitochondrial apoptosis. PLoS Pathogens, 4(5), e1000018. https://doi.org/10.1371/journal.ppat.1000018
  • Hanwell, M., Curtis, D., Lonie, D., Vandermeersch, T., Zurek, E., & Hutchison, G. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 17. (https://doi.org/10.1186/1758-2946-4-17
  • Hemmer, B., Kondo, T., Gran, B., Pinilla, C., Cortese, I., Pascal, J., Tzou, A., McFarland, H. F., Houghten, R., & Martin, R. (2000). Minimal peptide length requirements for CD4(+) T cell clones-implications for molecular mimicry and T cell survival. International Immunology, 12(3), 375–383. https://doi.org/10.1093/intimm/12.3.375
  • Kale, J., Osterlund, J. E., & Andrews, W. D. (2018). BCL-2 family proteins: Changing partners in the dance towards death. Cell Death and Differentiation, 25(1), 65–80. https://doi.org/10.1038/cdd.2017.186
  • Kelly, G. L., Long, H. M., Stylianou, J., Thomas, W. A., Leese, A., Bell, A. I., Bornkamm, G. W., Mautner, J., Rickinson, A. B., & Rowe, M. (2009). An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathogens, 5(3), e1000341. https://doi.org/10.1371/journal.ppat.1000341
  • Lee, E. F., & Fairlie, W. D. (2019). The structural biology of Bcl-xL. International Journal of Molecular Sciences, 20(9), 2234. https://doi.org/10.3390/ijms20092234
  • Pang, X., & Zhou, H. X. (2017). Rate constants and mechanisms of protein-ligand binding. Annual Review of Biophysics, 46, 105–130. https://doi.org/10.1146/annurev-biophys-070816-033639
  • Pekka, M., & Lennart, N. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
  • Procko, E., Berguig, G. Y., Shen, B. W., Song, Y., Frayo, S., Convertine, A. J., Margineantu, D., Booth, G., Correia, B. E., Cheng, Y., Schief, W. R., Hockenbery, D. M., Press, O. W., Stoddard, B. L., Stayton, P. S., & Baker, D. (2014). A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells. Cell, 157(7), 1644–1656. https://doi.org/10.1016/j.cell.2014.04.034
  • Reddy, C. N., & Sankararamakrishnan, R. (2021). Designing BH3-mimetic peptide inhibitors for the viral Bcl-2 homologues A179L and BHRF1: Importance of long-range electrostatic interactions. ACS Omega, 6(41), 26976–26989. https://doi.org/10.1021/acsomega.1c03385
  • Shamas-Din, A., Kale, J., Leber, B., & Andrews, D. W. (2013). Mechanisms of action of Bcl-2 family proteins. Cold Spring Harbor Perspectives in Biology, 5(4), a008714. https://doi.org/10.1101/cshperspect.a008714
  • Turner, P. J. (2005). XMGRACE, version 5.1. 19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology.
  • Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
  • Wong, R. S. (2011). Apoptosis in cancer: From pathogenesis to treatment. Journal of Experimental & Clinical Cancer Research : CR, 30(1), 87. https://doi.org/10.1186/1756-9966-30-87
  • Yan, N., & Chen, Z. J. (2012). Intrinsic antiviral immunity. Nature Immunology, 13(3), 214–222. https://doi.org/10.1038/ni.2229

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.